EUVIMEDEUVIMED entdecken
Crossref

L26/P-799 Polycystic ovary syndrome is ameliorated by exercise via Improving LONP1-mediated mitochondrial proteostasis

C. Shin, L.W. Chen, M. Du

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.1126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von C. Shin und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does aerobic exercise prevent PCOS development by restoring ovarian mitochondrial proteostasis and normalizing steroidogenic enzyme turnover in a DHEA-induced mouse model? Summary answer Exercise attenuated PCOS development and pathology through normalizing steroidogenic enzyme degradation via LONP1 upregulation, suppressing ovarian inflammation and fibrosis, and activating mitochondrial biogenesis pathways. What is known already Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by hyperandrogenism, disrupted ovarian function, chronic low-grade inflammation, and metabolic abnormalities. Mitochondrial dysfunction and impaired energy metabolism have been increasingly implicated in PCOS pathophysiology, particularly in the regulation of ovarian steroidogenesis. Exercise is widely recognized as an effective non-pharmacological intervention for improving reproductive and metabolic outcomes in PCOS. However, the molecular mechanisms by which exercise modulates ovarian steroidogenic pathways during PCOS development, particularly through mitochondrial protein quality control systems, remain poorly understood. Study design, size, duration Wild-type C57BL/6J female mice at 9 weeks old were randomly distributed into three experimental groups: Control (CON), dehydroepiandrosterone (DHEA), and DHEA with Exercise (DHEA + EX). To establish the PCOS model, mice were subcutaneously injected daily with DHEA (60 mg/kg/body weight) for 21 consecutive days. To analyze the preventive effect of exercise on PCOS development, DHEA + EX group was concurrently applied to treadmill exercise during the DHEA injection period Participants/materials, setting, methods Mice were housed under standardized laboratory conditions. The exercise intervention consisted of treadmill running for 1 hour per day, 6 days per week, for 21 days. Estrous cyclicity was assessed by daily vaginal smear analysis. Ovarian morphology and fibrosis were evaluated using H&E and Masson’s trichrome staining. Serum lipid profiles and hormone levels were measured. Ovarian expression of inflammatory, fibrotic, steroidogenic, and mitochondrial-related genes and proteins was assessed using RT-qPCR and immunoblotting. Main results and the role of chance DHEA administration induced hallmark PCOS phenotypes, including disrupted estrous cycles, cystic follicle formation, reduced corpora lutea, ovarian inflammation, and fibrotic remodeling, accompanied by dyslipidemia and hyperandrogenism. At the mitochondrial level, DHEA markedly suppressed ovarian LONP1 expression and AMPK activation, impaired mitochondrial biogenesis signaling, and reduced mtDNA copy number, indicating disrupted mitochondrial proteostasis and energy homeostasis. Concurrent aerobic exercise significantly attenuated these pathological alterations. Exercise restored estrous cyclicity, reduced cystic follicle formation, and suppressed ovarian inflammatory and fibrotic markers while normalizing lipid and hormone profiles. Notably, exercise limited the accumulation of the steroidogenic acute regulatory protein (StAR) and key enzyme CYP11A1. Given that LONP1 is an ATP-dependent mitochondrial protease, restoration of LONP1 activity by exercise likely enhanced steroidogenic protein turnover, thereby preventing aberrant accumulation of StAR and CYP11A1 in PCOS ovaries. Mechanistically, exercise reactivated the LONP1–AMPK axis and upregulated key mitochondrial biogenesis regulators, including PGC-1α and PPARα, restoring mitochondrial proteostasis and functional homeostasis. This study identified mitochondrial proteolytic quality control mediated by LONP1 as a previously unrecognized mechanism underlying the therapeutic effects of exercise in PCOS. Limitations, reasons for caution The study used a preventive mouse model with exercise applied during PCOS induction, which may not fully represent established PCOS or human disease. Some effects may reflect exercise-associated prevention of weight gain. Wider implications of the findings This study highlights mitochondrial proteostasis as a key mechanistic axis mediating exercise-induced suppression of PCOS development, linking mitochondrial quality control with steroidogenic enzyme turnover and ovarian functional integrity. These findings extend current concepts of exercise action beyond metabolic regulation to mitochondrial protein homeostasis in the ovary. Trial registration number No

Zitieren

APA

Shin, C., Chen, L., & Du, M. (2026). L26/P-799 Polycystic ovary syndrome is ameliorated by exercise via Improving LONP1-mediated mitochondrial proteostasis. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1126

Vancouver

Shin C, Chen L, Du M. L26/P-799 Polycystic ovary syndrome is ameliorated by exercise via Improving LONP1-mediated mitochondrial proteostasis. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1126

BibTeX
@article{Shin2026,
  author = {Shin, C. and Chen, L.W. and Du, M.},
  title = {L26/P-799 Polycystic ovary syndrome is ameliorated by exercise via Improving LONP1-mediated mitochondrial proteostasis},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.1126}
}
Kostenlos starten →